Effect of rising hCG levels on the human corpus luteum during early pregnancy

Human Reproduction

Volumn 23, Issue 12, 2008, Pages 2775-2781

  Järvelä, Ilkka Y ^a   Ruokonen, Aimo ^a   Tekay, Aydin ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Estradiol; Gestational sac; Luteoplacental shift; Placenta; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN;

ARTICLE; CORPUS LUTEUM; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; OVARY BLOOD FLOW; PLACENTA; PROGESTERONE BLOOD LEVEL; PROGESTERONE SYNTHESIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY; VASCULARIZATION;

EID: 56749156902     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den299     Document Type: Article

References (32)

1. Bischof P, DuBerg S, Herrmann W, Sizonenko PC. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol 1981;88:973-975.
2. Csapo AI, Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 1978;33:69-81.
3. Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973;115:759-765.
4. Devoto L, Kohen P, Gonzalez RR, Castro O, Retamales I, Vega M, Carvallo P, Christenson LK, Strauss JF 3rd. Expression of steroidogenic acute regulatory protein in the human corpus luteum throughout the luteal phase. J Clin Endocrinol Metab 2001;86:5633-5639.
5. Devoto L, Kohen P, Vega M, Castro O, Gonzalez RR, Retamales I, Carvallo P, Christenson LK, Strauss JF. Control of human luteal steroidogenesis. Mol Hum Reprod 2002;186:137-141.
6. Dharmarajan AM, Bruce NW, Meyer GT. Quantitative ultrastructural characteristics relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant rat. Am J Anat 1985;172:87-99.
7. Duncan WC, Cowen GM, Illingworth PJ. Steroidogenic enzyme expression in human corpora lutea in the presence and absence of exogenous human chorionic gonadotrophin (HCG). Mol Hum Reprod 1999;5:291-298.
8. Fraser HM, Wulff C. Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 2003;1:88.
9. Fraser HM, Bell J, Wilson H, Taylor PD, Morgan K, Anderson RA, Duncan WC. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 2005;90:427-434.
10. Gaytan F, Morales C, Garcia-Pardo L, Reymundo C, Bellido C, Sanchez-Criado JE. A quantitative study of changes in the human corpus luteum microvasculature during the menstrual cycle. Biol Reprod 1999;60:914-919.
11. Hay DL. Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-1275.
12. Hazzard TM, Stouffer RL. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:883-900.
13. Järvelä IY, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Effect of pituitary down-regulation on the ovary before in vitro fertilization as measured using three-dimensional power Doppler ultrasound. Fertil Steril 2003a;79:1129-1135.
14. Järvelä IY, Sladkevicius P, Tekay AH, Campbell S, Nargund G. Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 2003b;21:277-282.
15. Järvelä IY, Niinimäki M, Martikainen H, Ruokonen A, Tapanainen JS. Ovarian response to the human chorionic gonadotrophin stimulation test in normal ovulatory women: the impact of regressing corpus luteum. Fertil Steril 2007;87:1122-1130.
16. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006;12:747-755.
17. Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, Raine-Fenning NJ. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod 2007;22:1932-1941.
18. Jokubkiene L, Sladkevicius P, Rovas L, Valentin L. Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Hum Reprod 2006;21:2661-2668.
19. Lee W, Deter RL, McNie B, Powell M, Balasubramaniam M, Goncalves LF, Espinoza J, Romero R. Quantitative and morphological assessment of early gestational sacs using three-dimensional ultrasonography. Ultrasound Obstet Gynecol 2006;28:255-260.
20. Miyazaki T, Tanaka M, Miyakoshi K, Minegishi K, Kasai K, Yoshimura Y. Power and colour Doppler ultrasonography for the evaluation of the vasculature of the human corpus luteum. Hum Reprod 1998;13:2836-2841.
21. Niemimaa M, Suonpaa M, Perheentupa A, Seppala M, Heinonen S, Laitinen P, Ruokonen A, Ryynanen M. Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland. Eur J Hum Genet 2001;9:404-408.
22. Niswender GD, Reimers TJ, Diekman MA, Nett TM. Blood flow: a mediator of ovarian function. Biol Reprod 1976;14:64-81.
23. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000;80:1-29.
24. Rodger FE, Young FM, Fraser HM, Illingworth PJ. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod 1997;12:1723-1729.
25. Sinosich MJ, Teisner B, Folkersen J, Saunders DM, Grudzinskas JG. Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem 1982;28:50-53.
26. Sugino N, Kashida S, Takiguchi S, Karube A, Kato H. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2000;85:3919-3924.
27. Tulchinsky D, Hobel CJ. Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy. Am J Obstet Gynecol 1973;117:884-893.
28. Tulchinsky D, Simmer HH. Sources of plasma 17alpha-hydroxyprogesterone in human pregnancy. J Clin Endocrinol Metab 1972;35:799-808.
29. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972;112:1095-1100.
30. Wulff C, Wilson H, Largue P, Duncan WC, Armstrong DG, Fraser HM. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 2000;85:4302-4309.
31. Wulff C, Dickson SE, Duncan WC, Fraser HM. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 2001a;16:2515-2524.
32. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 2001b;86:3377- 3386.